announced today that more than 97 percent of eligible claimants have opted into the product liability litigation settlement program announced on August 1, 2017 for cases brought against various Daiichi Sankyo and
S
Tokyo, Japan and Basking Ridge, NJ (Benicar, Benicar HCT, Azor and Tribenzor) and allegations that such products caused sprue-like enteropathy and other severe gastro-intestinal symptoms
Dangers Of Benicar The U
(“the Company”) announced today that it has reached a civil settlement with the U
Benicar is an angiotensin II receptor antagonist drug and was approved by the
It is manufactured by Daiichi Sankyo and had reportedly given the company success very early on
At that time, Daiichi TOKYO — Japanese drug maker Daiichi Sankyo Co
The complaints allege that Benicar and the company’s other olmesartan products, including Azor, Tribenzor and Benicar HCT
is suing Japanese pharmaceutical company Daiichi Sankyo for allegedly causing her to suffer chronic intestinal problems resulting from her use of the hypertension medication Benicar